Genomic studies of thyroid SMECE have so far been largely uninformative, showing a notable absence of MAML2 rearrangements characteristic of mucoepidermoid carcinoma or BRAF mutations [23–25]. The gene discussed is MAML2; the disease is mucoepidermoid carcinoma.